Receive our newsletter – data, insights and analysis delivered to you
  1. Deals Analysis
June 22, 2021

Europe’s medical devices industry saw a drop of 24.24% in deal activity during May 2021

Europe’s medical devices industry saw a drop of 24.24% in deal activity during May 2021, when compared with the last 12-month average, led by Murano Bidco’s $1.36bn acquisition of Vectura Group, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

 

A total of 25 medical devices industry deals worth $2.6bn were announced for the region in May 2021, against the 12-month average of 33 deals.

Of all the deal types, venture financing saw most activity in May 2021 with 13 transactions, representing a 52% share for the region.

Content from our partners
The added value of Qarad’s multilingual freephone service to their eIFU solution
Small and simple: how medical device manufacturers select materials
Precision wire: The future of bespoke medical treatment

In second place was M&A with seven deals, followed by private equity deals with five transactions, respectively capturing a 28% and 20% share of the overall deal activity for the month.

In terms of value of deals, M&A was the leading category in Europe’s medical devices industry with $1.91bn, while private equity and venture financing deals totalled $383.58m and $292.02m, respectively.

Europe medical devices industry deals in May 2021: Top deals

The top five medical devices deals accounted for 89.4% of the overall value during May 2021.

The combined value of the top five medical devices deals stood at $2.31bn, against the overall value of $2.6bn recorded for the month.

The top five medical devices industry deals of May 2021 tracked by GlobalData were:

1) Murano Bidco’s $1.36bn acquisition of Vectura Group

2) The $390m acquisition deal with Inivata by NeoGenomics

3) IP Group, M&G Investments, Nikon, Temasek Holdings (Private) and Wellington ManagementLLP’s $280.17m private equity deal with Oxford Nanopore Technologies

4) The $155m acquisition of Immunodiagnostic Systems by PerkinElmer

5) HAT SGR, Hitachi Ventures, Leaps by Bayer, Samsung NEXT Fund, Sony Innovation Fund and Unilever Ventures’ venture financing of Huma Therapeutics for $130m.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU